Burgdorf, 07.03.2018, 2.00 p.m. - The guidance of CHF 60 million EBIT for the 2017/18 financial year announced in November 2017 remains unchanged. Ypsomed is investing in its global expansion and the establishment of new subsidiaries for the insulin pump business. Ypsomed expects sustained growth in the Ypsomed Delivery Systems (YDS) segment.
Burgdorf, 05.03. 2018, 7.00 a.m. - Swisscom and Ypsomed have been cooperating since the spring of 2017 to develop application options for the latest generation of mobile communications. Ypsomed has digitised selected production processes with 5G. This simplifies processes considerably, makes them even safer and more efficient.
Burgdorf, 23.02.2018, 7.00 a.m. – February 24th marks Equal Pay Day in Switzerland. Ypsomed already had Equal Pay Day on January 18th and is strongly committed to further reduce inequality in pay between men and women. Cross-divisional analyses and individual case studies ensure equal pay in the company over the long term.
Burgdorf, 31.01.2018, 7 a.m. – Ypsomed continues to expand its offers for digital diabetes therapy with the launch of the mylife™ App. The mylife™ App is connected to the mylife™ YpsoPump® insulin pump via Bluetooth® and continuously records current therapy data. Digital therapy solutions add to customer benefit and increase the success of therapy long-term.